Article

Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature review

2022-02-02

Abstract excerpt

<h4>Background: </h4> Coronavirus disease 2019 (COVID-19) is a new acute respiratory infectious disease that can lead to multiple organ dysfunction in severe patients. However, there is still a lack of effective antiviral drugs for COVID-19. Herein, we investigated the efficacy and safety of convalescent plasma (CP) in the treatment of severe COVID-19 in an attempt to explore new therapeutic methods. <h4>Methods:...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 35925ba2-4784-5d50-846b-1c7ccde5288a
DOI: 10.21203/rs.3.rs-1223109/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature reviewDOI 10.21203/rs.3.rs-1223109/v2Read

A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19Semantic proximity Read

Successful Treatment of Convalescent Plasma Therapy in Three Patients With Severe SARS-CoV-2 Infection in Fuzhou, ChinaSemantic proximity Read

Treatment of COVID-19 Patients with Convalescent Plasma in Houston, TexasSemantic proximity Read

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceSemantic proximity Read

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)Semantic proximity Read

Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community SettingSemantic proximity Read

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaSemantic proximity Read

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized TrialsSemantic proximity Read

COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trialSemantic proximity Read

Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,ChinaSemantic proximity Read

Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaSemantic proximity Read

Analysis of Clinical Characteristics of Patients with Critical COVID-19Semantic proximity Read